Skip to content

Clinical trials

Phase 2 Graft vs Host Disease trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Phase 2 Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20081
20091
20101
20121
20171
20182
20211
20221
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Unknown status3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nantes University Hospital3
Assistance Publique - Hôpitaux de Paris2
University Hospital, Clermont-Ferrand2
Central Hospital, Nancy, France1
Cynata Therapeutics Limited1
Institut Paoli-Calmettes1
Jazz Pharmaceuticals1
Mallinckrodt1
Syndax Pharmaceuticals1
University Hospital, Lille1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease14
Hematologic Neoplasms2
Hodgkin Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Non-Hodgkin2
Neoplasms, Plasma Cell2
Bronchiolitis Obliterans Syndrome1
Burkitt Lymphoma1
Congenital Abnormalities1
Immunoblastic Lymphadenopathy1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.